As approvals for cell and gene therapies (CGT) priced between $2 million and $5 million expand beyond ultra-rare cases with anywhere from 2,000 to 4,000 new scripts in development, self-funded ...

Test time has arrived: the first person has been treated in a highly anticipated gene therapy trial that aims to coax aged cells to take on a younger identity. The clinical trial will test a novel ...

An eagerly awaited and controversial clinical trial to 'wind back the clock' on aging cells in the eye and restore them to a more youthful state has officially begun. This week, the United States ...

Washington — The Justice Department on Tuesday accused the Equal Employment Opportunity Commission of violating federal civil rights laws by issuing guidelines that effectively pressured employers to ...

Using AI chatbots for even just 10 minutes may have a shockingly negative impact on people’s ability to think and problem-solve, according to a new study from researchers at Carnegie Mellon, MIT, ...

Researchers have found a reliable way to grow helper T cells from stem cells, solving a major challenge in immune-based cancer therapy. Helper T cells act as the immune system’s coordinators, helping ...

Chocolate bars made from lab-grown ingredients, rather than cocoa sourced from plantations, are no longer confined to science fiction. They are now a reality, with nearly a dozen such chocolate bars ...

For pathogens like HIV, malaria, and rapidly evolving influenza strains, coaxing the immune system to produce the rare, highly potent antibodies needed for protection has long been a scientific ...

The core promise of new AI platforms is that you can describe your task to the AI assistant, let it plan the task and use the relevant tools for you, and keep your preferences in mind for future tasks ...